Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Jun 30, 2018
Jun 30, 2017
Jun 30, 2016
Jun 30, 2015
Total Revenue
684,563
633,341
542,493
406,837
Cost of Revenue
395,857
300,030
256,000
100,481
Gross Profit
288,706
333,311
286,493
306,356
Operating Expenses
Research Development
29,196
42,073
45,054
30,342
Selling General and Administrative
82,196
73,477
68,325
49,527
Non Recurring
--
--
7,166
--
Others
0
32,098
35,190
0
Total Operating Expenses
111,392
147,648
155,735
79,869
Operating Income or Loss
177,314
185,663
130,758
226,487
Income from Continuing Operations
Total Other Income/Expenses Net
(40,587)
(95,693)
(2,642)
717
Earnings Before Interest And Taxes
136,727
89,970
128,116
227,629
Interest Expense
85,634
89,420
65,937
207
Income Before Tax
51,093
550
62,179
227,422
Income Tax Expense
22,403
1,097
17,322
77,430
Minority Interest
0
0
408
353
Net Income From Continuing Ops
28,690
(547)
44,857
149,992
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
(34)
(75)
(73)
Net Income
28,690
(581)
44,782
149,919
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
28,690
(581)
44,782
149,919